|
Vaccine Comparison
Leptospira interrogans DNA vaccine ompL1-pcDNA3.1(+) |
Leptospira interrogans DNA vaccine pTARGET/ LigBrep |
Vaccine Information |
Vaccine Information |
- Vaccine Ontology ID: VO_0004562
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Hamsters
- ompL1
gene engineering:
- Type: DNA vaccine construction
- Detailed Gene Information: Click Here.
- Vector: pcDNA3.1(+) (Maneewatch et al., 2007)
- Immunization Route: Intramuscular injection (i.m.)
|
- Vaccine Ontology ID: VO_0004563
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Hamsters
- ligB
gene engineering:
- Type: DNA vaccine construction
- Detailed Gene Information: Click Here.
- Vector: pTARGET (Forster et al., 2013)
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Host Response |
Hamster Response
- Vaccine Immune Response Type: VO_0003057
- Efficacy: The vaccine was shown to confer the delay in the death time and reduced morbidity in the vaccinated animals when compared to animals immunized with the plasmid alone or PBS. Hamsters of group 2 (mock) and group 3 (positive leptospirosis) were all dead between days 5 and 6 post-challenge. For the vaccinated group, two hamsters were dead on day 9, one each died on days 11 and 18, respectively. Two hamsters survived the lethal Leptospira challenge until day 21 when they were sacrificed (Maneewatch et al., 2007).
|
Hamster Response
- Vaccine Immune Response Type: VO_0003057
- Immune Response: The vaccine induced an IgG antibody response and, additionally, conferred sterilizing immunity in 80% of the surviving animals (Forster et al., 2013).
- Efficacy: Immunization with a DNA vaccine encoding LigBrep resulted in the survival of 5/8 (62.5%) hamsters against lethal infection (P < 0.05). None of the control hamsters or animals immunized with the other vaccine preparations survived (Forster et al., 2013).
|
References |
References |
Maneewatch et al., 2007: Maneewatch S, Tapchaisri P, Sakolvaree Y, Klaysing B, Tongtawe P, Chaisri U, Songserm T, Wongratanacheewin S, Srimanote P, Chongsa-nguanz M, Chaicumpa W. OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge. Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand. 2007; 25(1); 75-82. [PubMed: 17891923].
|
Forster et al., 2013: Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M, Hartleben CP, Dellagostin OA. A Conserved Region of Leptospiral Immunoglobulin-Like A and B Proteins as a DNA Vaccine Elicits a Prophylactic Immune Response against Leptospirosis. Clinical and vaccine immunology : CVI. 2013; 20(5); 725-731. [PubMed: 23486420].
|
|